5 Recruiting Non-small Cell Lung Cancer (NSCLC) Phase 1 / Phase 2 Clinical Trials

Active phase 1 / phase 2 studies for non-small cell lung cancer (nsclc) enrolling across the USA. Verify eligibility and contact site coordinators.

All Non-small Cell Lung Cancer (NSCLC) studies

Phase 1 / Phase 2 Studies for Non-small Cell Lung Cancer (NSCLC)

🔵 Active, Not Recruiting Phase1 / Phase2

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

📍 Henry Ford Health — Detroit, Michigan

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

📍 City of Hope — Duarte, California

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

📍 UC Irvine/Chao Family Comprehensive Cancer Center — Orange, California

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

📍 Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium) — Nashville, Tennessee

View Study & Checklist ➔